Answers are grounded in this paper and cite their sources.
Deubiquitinating enzymes (DUBs) are a class of isopeptidases that catalyze the removal of ubiquitin from protein substrates or ubiquitin chains, thereby playing a critical role in maintaining cellular homeostasis. Consequently, dysregulation of DUB activity has been implicated in a wide range of diseases, including cancer and neurodegeneration. To better understand the DUB function, chemical probes, small molecules specifically designed to modulate protein function, have emerged as powerful tools. These probes enable precise manipulation of DUB activity, allowing researchers to directly interrogate their enzymatic activity in complex biological systems. By facilitating mechanistic studies and target validation, chemical probes are instrumental in elucidating DUB biology and hold significant promise for therapeutic development. Here, we discuss the evolution of DUB-targeting chemical probes, from early promiscuous inhibitors to highly selective modulators. Focusing on two extensively studied enzymes, USP7 and UCHL1, we highlight how advances in probe design have aided both mechanistic insight and the development of selective modulators.
No takes yet. Share an insight, caveat, or question.
Neri et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: